Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950144-07-008713
Filing Date
2007-09-20
Accepted
2007-09-19 21:51:24
Documents
4
Period of Report
2006-12-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PROTALIX BIOTHERAPEUTICS INC. g09552e8vkza.htm 8-K/A 12997
2 EX-10.6 LICENSE AGREEMENT g09552exv10w6.htm EX-10.6 111139
3 EX-10.7 RESEARCH & LICENSE AGREEMENT g09552exv10w7.htm EX-10.7 263448
4 EX-10.8 AGREEMENT BETWEEN TEVA & PROTALIX g09552exv10w8.htm EX-10.8 272624
  Complete submission text file 0000950144-07-008713.txt   661921
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33357 | Film No.: 071125822
SIC: 2836 Biological Products, (No Diagnostic Substances)